(Q102139902)

English

Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study

scientific article published on 17 November 2020

Statements

Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit